Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-alpha in combination with ribavirin and amantadine: a two-arm randomized pilot study-Reference-Cited by-同舟云学术

Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-alpha in combination with ribavirin and amantadine: a two-arm randomized pilot study

Published:2003-05 Issue:3 Volume:10 Page:174-182
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Weegink C. J.,Sentjens R. E.,Beld M. G.,Dijkgraaf M. G. W.,Reesink H. W.

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2893.2003.00421.x/fullpdf

Reference21 articles.

1. Management of interferon relapsers

2. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

4. A short induction regimen of interferon-α is not effective for treatment of relapse in chronic hepatitis C: a randomized trial

5. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter, controlled, randomized trial

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic HCV and HIV Coinfection;Chronic Hepatitis C Virus;2011-10-11

2. Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target;Liver International;2011-01-24

3. Prediction of virologic response in difficult-to-treat chronic hepatitis C patients during high-dose interferon induction therapy;Scandinavian Journal of Gastroenterology;2008-01

4. Relapse to prior therapy is the most important factor for the retreatment response in patients with chronic hepatitis C virus infection;Liver International;2007-09

5. Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study;Journal of Viral Hepatitis;2007-04-18